We speculate that EGFR VUSs (KD +) and rare EGFR mutations are within the same cancer cell or even on the same allele, and the additional KD aberrations from the VUSs might help reinforce the oncogenic activities of rare EGFR mutations. The gene discussed is EGFR; the disease is cancer.